1. Home
  2. PRAX vs AUR Comparison

PRAX vs AUR Comparison

Compare PRAX & AUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$295.56

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo Aurora Innovation Inc.

AUR

Aurora Innovation Inc.

HOLD

Current Price

$4.43

Market Cap

8.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
AUR
Founded
2015
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
8.5B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
PRAX
AUR
Price
$295.56
$4.43
Analyst Decision
Strong Buy
Buy
Analyst Count
15
5
Target Price
$572.13
$10.34
AVG Volume (30 Days)
298.8K
16.6M
Earning Date
05-01-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$408.03
Revenue Next Year
$6,395.88
$1,167.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.70
$3.60
52 Week High
$354.87
$8.25

Technical Indicators

Market Signals
Indicator
PRAX
AUR
Relative Strength Index (RSI) 42.98 51.75
Support Level $290.36 $4.13
Resistance Level $322.32 $4.96
Average True Range (ATR) 16.81 0.24
MACD -2.42 -0.02
Stochastic Oscillator 26.09 64.63

Price Performance

Historical Comparison
PRAX
AUR

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About AUR Aurora Innovation Inc.

Aurora Innovation Inc delivers self-driving technology safely, quickly, and broadly. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles. It underpins Aurora Horizon and Aurora Connect, its driver-as-a-service products for trucking and ride-hailing. The Company is developing the Aurora Driver, a scalable suite of self-driving hardware, software, and data services designed as a platform to adapt and interoperate among vehicle types and applications.

Share on Social Networks: